Drug recall
Blood and Blood Products for Reprocessing
FDA recall event 50403 · Class II · Belle Bonfils Memorial Blood Center
Key facts
| Event ID | 50403 |
|---|---|
| Recall numbers | B-1795-12, B-1796-12 |
| Recalling firm | Belle Bonfils Memorial Blood Center |
| Product type | Biologics |
| Products | Blood and Blood Products for Reprocessing, Red Blood Cells, Leukocytes Reduced. |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, collected from a donor with a history of Hepatitis A, were distributed. |
| Initiation date | Oct 8, 2008 |
| Report date | Jul 25, 2012 |
| Termination date | Jul 13, 2012 |
| City | Denver |
| State | CO |
| Country | United States |
| FEI number | 3000210247 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: